Publications

Role of innate lymphoid cells in cancer metastasis.

Authors: J Moreno-Vicente, TY Halim

E-pub date: 1 Oct 2023

Journal name: Int J Biochem Cell Biol

Efficient genetic editing of human intestinal organoids using ribonucleoprotein-based CRISPR.

Authors: N Skoufou-Papoutsaki, S Adler, P D'Santos, L Mannion, S Mehmed, R Kemp, A S...

E-pub date: 1 Oct 2023

Journal name: Dis Model Mech

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.

Authors: P Smith, T Bradley, LM Gavarró, T Goranova, DP Ennis, HB Mirza, D De Silva...

E-pub date: 26 Sep 2023

Journal name: Nat Commun

Unrepaired base excision repair intermediates in template DNA strands trigger replication fork collapse and PARP inhibitor sensitivity.

Authors: A Serrano-Benitez, SE Wells, L Drummond-Clarke, LC Russo, JC Thomas, GA Lea...

E-pub date: 18 Sep 2023

Journal name: EMBO J

Calibrating ensembles for scalable uncertainty quantification in deep learning-based medical image segmentation.

Authors: T Buddenkotte, L Escudero Sanchez, M Crispin-Ortuzar, R Woitek, C McCague, ...

E-pub date: 1 Sep 2023

Journal name: Comput Biol Med

#159 ICON8B: GCIG phase III randomised trial comparing weekly dose-dense chemotherapy + bevacizumab to three-weekly chemotherapy+ bevacizumab in first-line high-risk stage III-IV epithelial ovarian cancer treatment: primary progression-free survival analysis

Authors: A Clamp, I Mcneish, R Lord, M Hall, S Essapen, A Cook, R Agarwal, A Walther...

E-pub date: 1 Sep 2023

Journal name: International Journal of Gynecological Cancer

Spatial predictors of immunotherapy response in triple-negative breast cancer.

Authors: XQ Wang, E Danenberg, C-S Huang, D Egle, M Callari, B Bermejo, M Dugo, C Za...

E-pub date: 1 Sep 2023

Journal name: Nature

Chem-map profiles drug binding to chromatin in cells.

Authors: Z Yu, J Spiegel, L Melidis, WWI Hui, X Zhang, A Radzevičius, S Balasubrama...

E-pub date: 1 Sep 2023

Journal name: Nat Biotechnol

Filters

Research Groups

Core Facilities

Start date

End date

Role of innate lymphoid cells in cancer metastasis.

Efficient genetic editing of human intestinal organoids using ribonucleoprotein-based CRISPR.

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.

Unrepaired base excision repair intermediates in template DNA strands trigger replication fork collapse and PARP inhibitor sensitivity.

Calibrating ensembles for scalable uncertainty quantification in deep learning-based medical image segmentation.

#159 ICON8B: GCIG phase III randomised trial comparing weekly dose-dense chemotherapy + bevacizumab to three-weekly chemotherapy+ bevacizumab in first-line high-risk stage III-IV epithelial ovarian cancer treatment: primary progression-free survival analysis

Spatial predictors of immunotherapy response in triple-negative breast cancer.

Chem-map profiles drug binding to chromatin in cells.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Role of innate lymphoid cells in cancer metastasis.

Efficient genetic editing of human intestinal organoids using ribonucleoprotein-based CRISPR.

Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.

Unrepaired base excision repair intermediates in template DNA strands trigger replication fork collapse and PARP inhibitor sensitivity.

Calibrating ensembles for scalable uncertainty quantification in deep learning-based medical image segmentation.

#159 ICON8B: GCIG phase III randomised trial comparing weekly dose-dense chemotherapy + bevacizumab to three-weekly chemotherapy+ bevacizumab in first-line high-risk stage III-IV epithelial ovarian cancer treatment: primary progression-free survival analysis

Spatial predictors of immunotherapy response in triple-negative breast cancer.

Chem-map profiles drug binding to chromatin in cells.